Anonymous (2000) Half of health authorities fail to fund Alzheimer's drugs. Progress in Neurology and Psychiatry, 4, 14–15.
Ballard, C. & O'Brien, J. (1999) Treating behavioural and psychological signs in Alzheimer dementia. BMJ, 319, 138–139.
Beck, S., Paton, C., Euba, R.
et al (2001) Atypical antipsychotics in the elderly. International Journal of Psychiatry in Clinical Practice, in press.
British Medical Association & Law Society (1995) Assessment of Mental Capacity, Guidance for Doctors and Lawyers. London: BMA.
British Medical Journal Legal Correspondent (1985) What should a doctor tell. BMJ, 290, 780–781.
Collier, J. (1998) Patient information leaflets and prescriber compliance. Lancet, 353, 1724.
Evans, M., Hammond, M., Wilson, K.
et al (1997) Placebo-controlled treatment trial of depression in elderly physically ill patients. International Journal of Geriatric Psychiatry, 12, 817–824.
Katz, I. R., Jeste, D. V., Mintzer, J. E.
et al (1999) Comparison of risperidone and placebo for psychosis and behavioral disturbances associated with dementia: a randomized, double-blind trial. Journal of Clinical Psychiatry, 60, 107–115.
Kirchner, V., Kelly, C. A. & Harvey, R. J. (2000). Thioridazine for dementia. Cochrane Library, issue 4. Oxford: Update Software.
The Lord High Chancellor (1999) Making Decisions. The Government's Proposals for Making Decisions on Behalf of Incapable Adults. London: Stationery Office.
Lyketsos, C. G., Steele, C., Galik, E.
et al (1999) Physical aggression in dementia patients and its relationship to depression. American Journal of Psychiatry, 156, 66–71.
Macdonald, A. J. D. (1998) Mental Health in Old Age. In ABC of Mental Health (eds Davies, T. & Craig, T. K. J.) pp. 46–50. London: BMJ Books.
Mayersohn, M. (1986) Special pharmacokinetic considerations in the elderly. In Applied Pharmacokinetics Principles of Therapeutic Drug Monitoring (eds Evans, W. E., Schentag, J. J. & Jusko, W. J.) pp. 229–293. Spokane, WA: Applied Therapeutics Inc.
National Institute for Clinical Excellence (NICE) (2001) Guidance on the use of donepezil, rivastigmine and galantamine for the treatment of Alzheimer's disease. Technology Guidance, no. 21. London: NICE.
National Institutes for Health Consensus Development Panel on Depression in Late Life (1992) NIH Concensus Conference. Diagnosis and treatment of depression in late life. JAMA, 268, 1018–1024.
Royal College of Physicians (1997) Medication for older people. Summary and recommendations of a report of a working party of the Royal College of Physicians. Journal of the Royal College of Physicians of London, 3, 254–257.
Street, J. S., Scott Clark, W., Gannon, K. S.
et al (2000) Olanzapine treatment of psychosis and behavioural symptoms in patients with Alzheimer's disease in nursing care facilities. Archives of General Psychiatry, 57, 968–976.
Thacker, S. (1996) Nurses' and doctors' expectations towards neuroleptic response in dementia. Psychiatric Bulletin, 20, 670–672.
Treloar, A. (1999) Advance directives: limitations upon their applicability in elderly care. International Journal of Geriatric Psychiatry, 14, 1039–1043.
Treloar, A., Beats, B. & Philpot, M. (2000) A pill in the sandwich: covert medication in food and drink. Journal of the Royal Society Medicine, 93, 408–411.
Treloar, A., Philpot, M & Beats, B. (2001) Concealing medication in patients' food. Lancet, 357, 62–64.
Zaleon, C. R. & Guthrie, S. K. (1994) Antipsychotic drug use in older adults. American Journal of Hospital Pharmacology, 51, 2917–2943.
Re C (Adult Refusal of Treatment)  1 WLR 290.
Re F (Mental Patient: Schizophrenia: Sterilization)  2 AC 1.
R v. Bournewood Community and Mental Health NHS Trust, ex Parte L  3 AllER 289Sidaway v. Board of Governors of the Bethlem Royal Hospital and Maudsley Hospital  AC 871.